Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05625425 · ClinicalTrials.gov registry record · NA

Wayfinding Intervention and Long-Term Memory

A NA study of Mild Cognitive Impairment and Long-Term Memory Decline, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05625425: Recruiting NA study of Mild Cognitive Impairment and Long-Term Memory Decline, sponsored by University of California, San Francisco.

NCT05625425 is a NA study of Mild Cognitive Impairment and Long-Term Memory Decline that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05625425, a NA study of Mild Cognitive Impairment and Long-Term Memory Decline, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that can restore memory capability or provide therapeutic treatment for memory deficits.

Primary Outcome

Training-related change in Mnemonic Discrimination Task (MDT) score. MDT tests recognition memory for pairs of common objects (i.e., targets and lures), measuring the variable of the number of images identified as old (studied) or new (novel), and reports a composite index score (0.00 to 1.00) for accuracy post-training (T2) versus baseline (T1)

Conditions Studied

Mild Cognitive Impairment Long-Term Memory Decline

Interventions

  • BEHAVIORAL LabyrinthVR software
  • BEHAVIORAL Placebo Games software
  • BEHAVIORAL Labyrinth Tablet software
  • BEHAVIORAL Labyrinth VR wireless

Study Locations (1)

California

  • UCSF Mission Bay - San Francisco

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-01-01
Est. Completion 2027-01-31
Phase NA
University of California, San Francisco

1,713 total trials

What NCT05625425 shows while recruiting

NCT05625425 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 4 interventions - of which LabyrinthVR software is the first listed.

NCT05625425 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05625425 about?

NCT05625425 is a clinical study titled "Wayfinding Intervention and Long-Term Memory". Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that ...

What is the current status of trial NCT05625425?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-01-01. Estimated completion is 2027-01-31.

What conditions does trial NCT05625425 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Long-Term Memory Decline.

What interventions are being tested in trial NCT05625425?

The interventions under investigation include: LabyrinthVR software (BEHAVIORAL), Placebo Games software (BEHAVIORAL), Labyrinth Tablet software (BEHAVIORAL), Labyrinth VR wireless (BEHAVIORAL).

Who is sponsoring clinical trial NCT05625425?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05625425 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05625425's enrollment target sits among peer trials

200 46th of 205 higher than 155 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05625425

Source: ClinicalTrials.gov NCT05625425, the US trial registry maintained by the National Library of Medicine. NCT05625425 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.